News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
779,955 Results
Type
Article (55266)
Company Profile (494)
Press Release (724182)
Multimedia
Podcasts (140)
Webinars (22)
Section
Business (217558)
Career Advice (2879)
Deals (37398)
Drug Delivery (139)
Drug Development (87239)
Employer Resources (185)
FDA (17427)
Job Trends (16002)
News (369790)
Policy (35766)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2933)
Academic (1)
Accelerated approval (36)
Adcomms (33)
Allergies (153)
Alliances (53291)
ALS (183)
Alzheimer's disease (1790)
Antibody-drug conjugate (ADC) (346)
Approvals (17627)
Artificial intelligence (575)
Autoimmune disease (166)
Automation (40)
Bankruptcy (391)
Best Places to Work (12281)
BIOSECURE Act (21)
Biosimilars (202)
Biotechnology (341)
Bladder cancer (165)
Brain cancer (63)
Breast cancer (674)
Cancer (5081)
Cardiovascular disease (442)
Career advice (2435)
Career pathing (41)
CAR-T (305)
CDC (54)
Celiac Disease (2)
Cell therapy (809)
Cervical cancer (37)
Clinical research (73995)
Collaboration (1850)
Company closure (4)
Compensation (1185)
Complete response letters (73)
COVID-19 (2938)
CRISPR (101)
C-suite (910)
Cystic fibrosis (153)
Data (6378)
Decentralized trials (2)
Denatured (43)
Depression (151)
Diabetes (528)
Diagnostics (7058)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (280)
Drug pricing (216)
Drug shortages (31)
Duchenne muscular dystrophy (247)
Earnings (92932)
Editorial (66)
Employer branding (23)
Employer resources (163)
Events (125797)
Executive appointments (1043)
FDA (20634)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1561)
Gene editing (217)
Generative AI (50)
Gene therapy (669)
GLP-1 (1096)
Government (5172)
Grass and pollen (8)
Guidances (385)
Healthcare (20249)
HIV (64)
Huntington's disease (48)
IgA nephropathy (88)
Immunology and inflammation (293)
Immuno-oncology (65)
Indications (111)
Infectious disease (3231)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (125)
Intellectual property (257)
Interviews (558)
IPO (17248)
IRA (59)
Job creations (4090)
Job search strategy (1981)
JPM (68)
Kidney cancer (18)
Labor market (86)
Layoffs (626)
Leadership (40)
Legal (8778)
Liver cancer (99)
Longevity (15)
Lung cancer (686)
Lymphoma (385)
Machine learning (43)
Management (63)
Manufacturing (839)
MASH (177)
Medical device (14464)
Medtech (14519)
Mergers & acquisitions (21224)
Metabolic disorders (1389)
Multiple sclerosis (169)
NASH (23)
Neurodegenerative disease (356)
Neuropsychiatric disorders (104)
Neuroscience (3126)
Neurotech (1)
NextGen: Class of 2026 (7256)
Non-profit (4933)
Now hiring (67)
Obesity (669)
Opinion (319)
Ovarian cancer (170)
Pain (216)
Pancreatic cancer (237)
Parkinson's disease (301)
Partnered (34)
Patents (516)
Patient recruitment (512)
Peanut (61)
People (64008)
Pharmaceutical (87)
Pharmacy benefit managers (31)
Phase 1 (23079)
Phase 2 (32453)
Phase 3 (24188)
Pipeline (5413)
Policy (328)
Postmarket research (2933)
Preclinical (9911)
Press Release (70)
Prostate cancer (251)
Psychedelics (58)
Radiopharmaceuticals (300)
Rare diseases (931)
Real estate (6474)
Recruiting (77)
Regulatory (26539)
Reports (53)
Research institute (2655)
Resumes & cover letters (456)
Rett syndrome (28)
RNA editing (21)
RSV (82)
Schizophrenia (161)
Series A (258)
Series B (203)
Service/supplier (13)
Sickle cell disease (105)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (44)
Startups (3953)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (95)
The Weekly (95)
Vaccines (1125)
Venture capital (99)
Weight loss (452)
Women's health (94)
Worklife (21)
Date
Today (20)
Last 7 days (634)
Last 30 days (2126)
Last 365 days (31383)
2026 (3633)
2025 (31809)
2024 (37082)
2023 (41872)
2022 (53195)
2021 (57849)
2020 (56585)
2019 (49820)
2018 (37672)
2017 (34679)
2016 (34495)
2015 (40593)
2014 (34629)
2013 (29927)
2012 (31959)
2011 (32437)
2010 (30693)
Location
Africa (934)
Alabama (91)
Alaska (7)
Arizona (327)
Arkansas (14)
Asia (44221)
Australia (7988)
California (11622)
Canada (3352)
China (1175)
Colorado (489)
Connecticut (500)
Delaware (345)
Europe (99134)
Florida (1710)
Georgia (365)
Hawaii (3)
Idaho (65)
Illinois (919)
India (69)
Indiana (532)
Iowa (24)
Japan (443)
Kansas (131)
Kentucky (42)
Louisiana (27)
Maine (72)
Maryland (1436)
Massachusetts (8441)
Michigan (338)
Minnesota (657)
Mississippi (6)
Missouri (140)
Montana (35)
Nebraska (28)
Nevada (125)
New Hampshire (85)
New Jersey (3089)
New Mexico (32)
New York (3066)
North Carolina (1585)
North Dakota (9)
Northern California (5642)
Ohio (343)
Oklahoma (21)
Oregon (46)
Pennsylvania (2330)
Puerto Rico (25)
Rhode Island (51)
South America (1304)
South Carolina (67)
South Dakota (1)
Southern California (4510)
Tennessee (178)
Texas (1795)
United States (41492)
Utah (347)
Vermont (1)
Virginia (275)
Washington D.C. (86)
Washington State (964)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
779,955 Results for "ebb therapeutics formerly known as cereve inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
November 18, 2025
·
2 min read
Press Releases
Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference
December 2, 2025
·
1 min read
Press Releases
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease
December 8, 2025
·
5 min read
Press Releases
Cerevance Announces Presentations at the Alzheimer’s Association International Conference 2025
July 14, 2025
·
3 min read
Press Releases
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting
November 24, 2025
·
2 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
September 12, 2025
·
4 min read
Press Releases
Cerevance to Participate in Piper Sandler Virtual CNS Symposium
August 13, 2025
·
1 min read
1 of 77,996
Next
